+Compare
HLVX
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
670.37M

HLVX HilleVax Forecast, Technical & Fundamental Analysis

Industry Biotechnology
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for HLVX with price predictions
07:00 PM EST Dec 04, 2023

HLVX's RSI Indicator recovers from overbought zone

The 10-day RSI Indicator for HLVX moved out of overbought territory on November 15, 2023. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 7 instances where the indicator moved out of the overbought zone. In of the 7 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HLVX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HLVX broke above its upper Bollinger Band on December 04, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 01, 2023. You may want to consider a long position or call options on HLVX as a result. In of 28 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HLVX just turned positive on October 31, 2023. Looking at past instances where HLVX's MACD turned positive, the stock continued to rise in of 10 cases over the following month. The odds of a continued upward trend are .

HLVX moved above its 50-day moving average on November 10, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HLVX crossed bullishly above the 50-day moving average on November 14, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HLVX advanced for three days, in of 93 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 22 cases where HLVX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.245) is normal, around the industry mean (20.694). P/E Ratio (0.000) is within average values for comparable stocks, (137.286). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (7.704). Dividend Yield (0.000) settles around the average of (0.035) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (329.913).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HLVX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLVX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Novavax (NASDAQ:NVAX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sorrento Therapeutics, Inc. (OTC:SRNEQ).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.3B. The market cap for tickers in the group ranges from 402 to 464.61B. NVO holds the highest valuation in this group at 464.61B. The lowest valued company is PNEXF at 402.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 12%. For the same Industry, the average monthly price growth was 25%, and the average quarterly price growth was 27%. CMND experienced the highest price growth at 3,849%, while BRRGF experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 37%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was 81%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 85
Price Growth Rating: 59
SMR Rating: 94
Profit Risk Rating: 94
Seasonality Score: 27 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

HLVX is expected to report earnings to rise 8.64% to -87 cents per share on March 15

HilleVax HLVX Stock Earnings Reports
Q4'23
Est.
$-0.88
Q3'23
Beat
by $0.01
Q2'23
Beat
by $0.15
Q1'23
Beat
by $0.27
Q4'22
Beat
by $0.89
The last earnings report on November 10 showed earnings per share of -81 cents, beating the estimate of -81 cents. With 59.28K shares outstanding, the current market capitalization sits at 670.37M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
75 State Street
Phone
+1 617 213-5054
Employees
62
Web
https://www.hillevax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSWEX13.01N/A
N/A
TSW Large Cap Value Institutional
CGCIX10.70-0.01
-0.09%
Calamos Global Opportunities I
CGVHX20.74-0.10
-0.48%
American Funds Global Insight 529-F-3
SZCAX42.28-0.33
-0.77%
DWS Small Cap Core A
MDBAX17.89-0.19
-1.05%
BlackRock Large Cap Focus Value Inv A

HLVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLVX has been loosely correlated with BEAM. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HLVX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLVX
1D Price
Change %
HLVX100%
-2.79%
BEAM - HLVX
34%
Loosely correlated
-4.47%
ACRV - HLVX
29%
Poorly correlated
+2.86%
SCPH - HLVX
28%
Poorly correlated
-2.25%
NTLA - HLVX
28%
Poorly correlated
-3.27%
DSGN - HLVX
27%
Poorly correlated
-0.81%
More